Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.

Process Mass Intensity (PMI): A Holistic Analysis of Current Peptide Manufacturing Processes Informs Sustainability in Peptide Synthesis

Open access
Kekessie, Ivy, Wegner, Katarzyna, Martinez, Isamir, Kopach, Michael E., White, Timothy D., Tom, Janine K., Kenworthy, Martin N., Gallou, Fabrice, Lopez, John, Koenig, Stefan G., Payne, Philippa R., Eissler, Stefan, Arumugam, Balasubramanian, Li, Changfeng, Mukherjee, Subha, Isidro-Llobet, Albert, Ludemann-Hombourger, Olivier, Richardson, Paul, Kittelmann, Jörg, Sejer Pedersen, Daniel, van den Bos, Leendert J. · 2024 · The Journal of Organic Chemistry

Abstract

Small molecule therapeutics represent the majority of the FDA-approved drugs. Yet, many attractive targets are poorly tractable by small molecules, generating a need for new therapeutic modalities. Due to their biocompatibility profile and structural versatility, peptide-based therapeutics are a possible solution. Additionally, in the past two decades, advances in peptide design, delivery, formulation, and devices have occurred, making therapeutic peptides an attractive modality. However, peptide manufacturing is often limited to solid-phase peptide synthesis (SPPS), liquid phase peptide synthesis (LPPS), and to a lesser extent hybrid SPPS/LPPS, with SPPS emerging as a predominant platform technology for peptide synthesis. SPPS involves the use of excess solvents and reagents which negatively impact the environment, thus highlighting the need for newer technologies to reduce the environmental footprint. Herein, fourteen American Chemical Society Green Chemistry Institute Pharmaceutical Roundtable (ACS GCIPR) member companies with peptide-based therapeutics in their portfolio have compiled Process Mass Intensity (PMI) metrics to help inform the sustainability efforts in peptide synthesis. This includes PMI assessment on 40 synthetic peptide processes at various development stages in pharma, classified according to the development phase. This is the most comprehensive assessment of synthetic peptide environmental metrics to date. The synthetic peptide manufacturing process was divided into stages (synthesis, purification, isolation) to determine their respective PMI. On average, solid-phase peptide synthesis (SPPS) (PMI ≈ 13,000) does not compare favorably with other modalities such as small molecules (PMI median 168-308) and biopharmaceuticals (PMI ≈ 8300). Thus, the high PMI for peptide synthesis warrants more environmentally friendly processes in peptide manufacturing.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acs.joc.3c01494

Cites

126 of 126 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Select mass based metrics.
Figure 1 Select mass based metrics.CC BY-NC-ND · PubMed Central
Figure 2 Illustration of solid vs liquid phase peptide synthesis cycles.
Figure 2 Illustration of solid vs liquid phase peptide synthesis cycles.CC BY-NC-ND · PubMed Central
Figure 3 Automatic 250 mL × 6 SPPS reactor.
Figure 3 Automatic 250 mL × 6 SPPS reactor.CC BY-NC-ND · PubMed Central
Figure 4 Automatic 2 L × 4 SPPS reactor.
Figure 4 Automatic 2 L × 4 SPPS reactor.CC BY-NC-ND · PubMed Central
Figure 5 Semiautomatic 100 L SPPS reactor.
Figure 5 Semiautomatic 100 L SPPS reactor.CC BY-NC-ND · PubMed Central
Figure 6 1000 L SPPS reactor.
Figure 6 1000 L SPPS reactor.CC BY-NC-ND · PubMed Central
Figure 7 6000 L SPPS system.
Figure 7 6000 L SPPS system.CC BY-NC-ND · PubMed Central
Figure 8 Large scale tray lyophilizer (with associated isolator).
Figure 8 Large scale tray lyophilizer (with associated isolator).CC BY-NC-ND · PubMed Central
Figure 9 Average PMI per AA for 34 SPPS processes per phase.
Figure 9 Average PMI per AA for 34 SPPS processes per phase.CC BY-NC-ND · PubMed Central
Figure 10 PMI for LPPS vs SPPS.
Figure 10 PMI for LPPS vs SPPS.CC BY-NC-ND · PubMed Central
Figure 11 Averages % of solvent usage of total PMI per process stage.
Figure 11 Averages % of solvent usage of total PMI per process stage.CC BY-NC-ND · PubMed Central
Figure 12 Overall solvent composition SPPS process.
Figure 12 Overall solvent composition SPPS process.CC BY-NC-ND · PubMed Central
Figure 13 Solvent composition (synthesis).
Figure 13 Solvent composition (synthesis).CC BY-NC-ND · PubMed Central
Figure 14 Solvent composition (purification).
Figure 14 Solvent composition (purification).CC BY-NC-ND · PubMed Central
Figure 15 BIT recyclable reagent for SPP.
Figure 15 BIT recyclable reagent for SPP.CC BY-NC-ND · PubMed Central
Figure 16 Soluble tags for LPPS. (A) Phosphonate tag where R = Cl, OH, and N-OH for DDK-Cl, DDK-OH, and DDK-NOH respectively. (B) Phosphonate tag where R = Cl, OH, and N-OH for TBP-Cl, TBP-OH, and TBP-NOH respectively and R1 = H or Cl. (C) Silylated tag B2STag. (D) Silylated tag B6-STag.
Figure 16 Soluble tags for LPPS. (A) Phosphonate tag where R = Cl, OH, and N-OH for DDK-Cl, DDK-OH, and DDK-NOH respectively. (B) Phosphonate tag where R = Cl, OH, and N-OH for TBP-Cl, TBP-OH, and TBP-NOH respectively and R1 = H or Cl. (C) Silylated tag B2STag. (D) Silylated tag B6-STag.CC BY-NC-ND · PubMed Central
Figure 17 DMB and DETB protected amino acids are synthesized from enamine precursors 1. Deprotection is achieved using hydrazine to give the amino acid/peptide product and a pyrazole byproduct.
Figure 17 DMB and DETB protected amino acids are synthesized from enamine precursors 1. Deprotection is achieved using hydrazine to give the amino acid/peptide product and a pyrazole byproduct.CC BY-NC-ND · PubMed Central
Figure 18 Diselenide-based organocatalyzed amide bonds, where R = desired AA side chain and X = AA residue.
Figure 18 Diselenide-based organocatalyzed amide bonds, where R = desired AA side chain and X = AA residue.CC BY-NC-ND · PubMed Central
Figure 19 Electrochemical peptide bond formation using triphenylphosphine, where PG = protecting group.
Figure 19 Electrochemical peptide bond formation using triphenylphosphine, where PG = protecting group.CC BY-NC-ND · PubMed Central
Figure 20 Peptide synthesis in water using a surfactant.
Figure 20 Peptide synthesis in water using a surfactant.CC BY-NC-ND · PubMed Central
Figure 21 Amide bond formation in water with addition of HPMC.
Figure 21 Amide bond formation in water with addition of HPMC.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 126 references

Research works printed but not linked: 7

  1. Blaha K., 2004, Chemicke Listy, 98, 875
  2. Sisniega E. C., 2008, Dyna, 83, 382
  3. Aguilar M. I., 2004, Methods in Molecular Biology, HPLC of Peptides and Proteins, Methods and Protocols
  4. Ludemann-Hombourger O., 2021, Chemistry Today, 39, 50
  5. Agency E. C., Restrictions on the Manufacture, Placing on the Market and Use of Certain Dangerous Substances, Mixtures and Articles
  6. Ravetti Duran R., 2022, Speciality Chemicals Magazine, 2022, 40
  7. Al Musaimi O., 2021, Chemistry Today, 39, 42

Cited by

Metadata

Authors
Kekessie, I., Wegner, K., Martinez, I., Kopach, M. E., White, T. D., Tom, J. K., Kenworthy, M. N., Gallou, F., Lopez, J., Koenig, S. G., Payne, P. R., Eissler, S., Arumugam, B., Li, C., Mukherjee, S., Isidro-Llobet, A., Ludemann-Hombourger, O., Richardson, P., Kittelmann, J., Sejer Pedersen, D., & van den Bos, L. J.
Affiliations
  • Roche (United States) (US)
  • Ipsen (Ireland) (IE)
  • Green Chemistry Institute, American Chemical Society, 1155 16th St North West, Washington, District of Columbia, 20036, United States
  • Eli Lilly (United States) (US)
  • Amgen (United States) (US)
  • AstraZeneca (United Kingdom) (GB)
  • Novartis (Switzerland) (CH)
  • Outsourced Manufacturing, Pharmaceutical Development & Manufacturing, Gilead Alberta ULC, 1021 Hayter Rd NW, Edmonton, T6S 1A1, Canada
  • Bachem (Switzerland) (CH)
  • Tianjin Economic-Technological Development Area (CN)
  • Bristol-Myers Squibb (United States) (US)
  • GSK, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
  • PolyPeptide Laboratories France SAS, 7 Rue de Boulogne, 67100 Strasbourg, France
  • Pfizer (United States) (US)
  • CMC API Development, Novo Allé, 2880 Bagsværd, Denmark
  • Chemical Development, Novo Allé, CMC API Development, 2880 Bagsværd, Denmark
  • EnzyTag B.V, Daelderweg 9, 6361HK, Nuth, Netherlands
Corresponding author
Kekessie, Ivy
Venue
The Journal of Organic Chemistry
Published
2024-03-20
Volume
89
Issue
7
Pages
4261-4282
ISSN
  • 0022-3263 (ISSN-L)
  • 1520-6904
OpenAlex
W4393022591
Cited by
149
References
126
Citations by year
2026: 74 · 2025: 60 · 2024: 15
FWCI
4.82
Type
journal article
Language
en
Open access
Locations
  • The Journal of Organic Chemistry (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • The Novartis Repository (Novartis) (submittedVersion)
Funders
American Chemical Society Green Chemistry Institute Pharmaceutical Roundtable
Topics
  • Physical Sciences › Environmental Science › Environmental Chemistry › Chemistry and Chemical Engineering
  • Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
  • Physical Sciences › Environmental Science › Environmental Engineering › Environmental Impact and Sustainability
Keywords
process mass intensity, solid-phase peptide synthesis, liquid-phase peptide synthesis, green chemistry, environmental footprint, peptide therapeutics, peptide purification
MeSH terms
Peptides, Solvents, Chemistry Techniques, Synthetic, Solid-Phase Synthesis Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.